David Dornan - CHIEF SCIENTIFIC OFFICER at Elevation Oncology, Inc.

Issuer-level insider activity

Role
Chief Scientific Officer
Issuer ticker
ELEV
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by David Dornan since 10 Sep 2025

Reported holdings for David Dornan in Elevation Oncology, Inc.

Form 4 holding CHIEF SCIENTIFIC OFFICER

Elevation Oncology, Inc.

Security class
Restricted Stock Unit
Shares / value
37,500
Estimated value
$19,125
Report date
15 Feb 2024
Price
$0.5100
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding CHIEF SCIENTIFIC OFFICER

Elevation Oncology, Inc.

Security class
Restricted Stock Unit
Shares / value
28,125
Estimated value
$18,892
Report date
15 Feb 2025
Price
$0.6717
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding CHIEF SCIENTIFIC OFFICER

Elevation Oncology, Inc.

Security class
Common Stock
Shares / value
5,223
Estimated value
$3,508
Report date
15 Feb 2025
Price
$0.6717
Ownership
Direct
Form 4 holding CHIEF SCIENTIFIC OFFICER

Elevation Oncology, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
225,000
Estimated value
Report date
15 Feb 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Transaction history for David Dornan in Elevation Oncology, Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .